BSE: APLLTD - Alembic Pharmaceuticals Limited

Yield per half year: -29.58%
Dividend yield: +0.87%

Share chart Alembic Pharmaceuticals Limited

Extended chart Simple chart
Financial Markets by TradingView

About Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products.

more details
The company was founded in 1907 and is headquartered in Vadodara, India.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN INE901L01018
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.8659
Дивиденд ао 11
Сайт https://alembicpharmaceuticals.com
Цена ао 827.95
Change price per day: +0.5556% (827.95)
Change price per week: -1.55% (845.65)
Change price per month: -1.5% (845.2)
Change price per 3 month: -21.56% (1061.35)
Change price per half year: -29.58% (1182.3)
Change price per year: -9.27% (917.65)
Change price per 3 year: +15.2% (722.7)
Change price per 5 year: +31.84% (631.5)
Change price per 10 year: 0% (832.55)
Change price per year to date: -20.56% (1048.05)
All parameters

Underestimation

Title Value Grade
P/S 2.49 6
P/BV 3.16 5
P/E 24.69 6
EV/EBITDA 17.77 6
Total: 6.5

Efficiency

Title Value Grade
ROA, % 9.55 3
ROE, % 12.78 4
Total: 2.5

Dividends

Title Value Grade
Div yield, % 0.8659 2.18
DSI 0.8571 8.57
Total: 4.14

Debt

Title Value Grade
Debt/EBITDA 1.06 8
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 32.71 5
Yield Ebitda, % -41.82 0
Yield EPS, % -18.89 0
Total: 1
More

ETF Share, % Profitability for 1 year, % Dividends, %
iShares MSCI India Small-Cap ETF 0.15813 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07481 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.05587 7.67 2.7853
WisdomTree India Earnings Fund 0.04848 5.23 1.65591
WisdomTree Emerging Markets SmallCap Dividend Fund 0.04404 1.35 5.00999
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Dimensional Emerging Markets Value ETF 0.01002 17.07 4.19508
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00961 12.46 3.59676
Dimensional Emerging Markets Core Equity 2 ETF 0.00845 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.00806 8.77 3.60513
Dimensional World ex U.S. Core Equity 2 ETF 0.00439 13.06 3.62488
SPDR Portfolio Emerging Markets ETF 0.00394 11.59 3.1879
Vanguard ESG International Stock ETF 0 6.39 3.07501

Head Job title Payment Year of birth
Mr. Pranav Chirayu Amin Managing Director 122.2M 1975 (50 years)
Mr. Shaunak Chirayu Amin MD & Executive Director 122.2M 1978 (47 years)
Mr. Vinod Kamath President of Operations N/A
Dr. J. Venkat Raman M. S., Ph.D. Chief Scientific Officer N/A 1958 (67 years)
Ms. Manisha Saraf Company Secretary & Compliance Officer N/A
Mr. Udit C. Amin Chief Business Development Officer N/A 1980 (45 years)
Mr. Gautam Chatterjee Senior Vice President N/A 1961 (64 years)
Mr. Chirayu Ramanbhai Amin Executive Chairman & CEO 88M 1946 (79 years)
Mr. Raj Kumar Shreeram Baheti B.Com.(Hon.), FCA, FCS Director of Finance, CFO & Executive Director 1959 (66 years)
Mr. Ajay Kumar Desai Senior Vice President of Finance

Address: India, Vadodara, Alembic Road - open in Google maps, open in Yandex maps
Website: https://alembicpharmaceuticals.com